| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc2b03342511abc88f60c63f2acd96d0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2537-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A90-10 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B40-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B25-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B20-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B40-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H20-10 |
| filingDate |
2020-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a285f10029c44d773faf88a049a6564f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_757405edded2415ef8bb4e2a3c85e315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53433f6f83a627c05f6f5b1ea29d3846
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_031f83af08fef9a8c09b3a94ccaaa904
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9c611d315a35557a22b98d9cc225a0c |
| publicationDate |
2022-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20220110751-A |
| titleOfInvention |
Tumor ecosystem deconvolution system and method for personalized cancer therapy |
| abstract |
Disclosed are methods and systems for deconvolution of tumor ecosystems for personalized cancer therapy. In general, human cancers show large variations in behavior between and within patients, mostly related to cell composition. Cell type identification can identify specific types of tumors and/or cancers present in an individual. Additional embodiments describe identifying therapies from clinical trials to which a tumor or cancer ecosystem generally responds, providing personalized therapies based on the identified cancer or tumor type. |
| priorityDate |
2019-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |